NewGenIvf (NIVFW) Current Deferred Revenue (2022 - 2025)

NewGenIvf (NIVFW) has 4 years of Current Deferred Revenue data on file, last reported at $111981.0 in Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $111981.0, up 76.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $111981.0 (up 76.38% YoY), and the FY2025 annual result was $111981.0, up 76.38% from the prior year.
• Current Deferred Revenue climbed to $111981.0 in Q4 2025 per NIVFW's latest filing, from $63489.0 in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $1.4 million in Q4 2022 and troughed at $7937.0 in Q4 2023.
• A 4-year average of $385893.8 and a median of $87735.0 in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue slumped 99.42% in 2023, then surged 699.91% in 2024.
• A 4-year view of Current Deferred Revenue shows it stood at $1.4 million in 2022, then slumped by 99.42% to $7937.0 in 2023, then surged by 699.91% to $63489.0 in 2024, then jumped by 76.38% to $111981.0 in 2025.
• Business Quant data shows NIVFW's Current Deferred Revenue at $111981.0 in Q4 2025, $63489.0 in Q4 2024, and $7937.0 in Q4 2023.